Stockscreener 앱 받기
12.16
8.61%
-1.32
전일 마감가:
$13.48
열려 있는:
$13.23
하루 거래량:
80,454
Relative Volume:
0.26
시가총액:
$670.59M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-12.93%
1개월 성능:
+187.18%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$11.48
$13.85
1주일 범위
$6.44
$14.30
52주 변동 폭
$3.50
$14.30
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Company Profile
명칭
Zhengye Biotechnology Holding Ltd
전화
-
주소
-
ZYBT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZYBT
Zhengye Biotechnology Holding Ltd
|
12.12 | 670.59M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
157.31 | 68.50B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.36 | 47.71B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.59 | 46.12B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.42 | 18.55B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
296.10 | 13.40B | 2.76B | 1.11B | 898.10M | 22.77 |
Zhengye Biotechnology Holding Ltd 주식(ZYBT)의 최신 뉴스
Why Meta Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket - Benzinga
Zhengye Biotechnology Holding Ltd Inc. (ZYBT) Price Performance: A Technical Analysis Perspective - investchronicle.com
Zhengye Biotechnology Delays 20-F Filing - TipRanks
Zhengye Biotechnology Holding Ltd (ZYBT) Surges 35% - Energy & Capital
Zhengye Biotechnology Holding Ltd (ZYBT): Why Shares Soared 34.91% in a Single Day - Energy & Capital
Understanding ZYBT stock ratios for better investment decisions - uspostnews.com
Navigating ZYBT Stock: Zhengye Biotechnology Holding Ltd Journey - investchronicle.com
A Closer Look At Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) Uninspiring ROE - simplywall.st
Should We Be Cautious About Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) ROE Of 6.9%? - Yahoo Finance
Zhengye Biotechnology Forms Joint Venture to Expand Poultry Vaccine Sales - TipRanks
Nvidia, Tesla Slide Among Mega-Cap Movers on Wednesday By Investing.com - Investing.com Canada
Pre-market Movers: OSRH, SURG, BLNE, HUMA, TNON… - RTTNews
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Kuke Music Holding Ltd ADR’s: Contrasting Stock Performances in a Volatile Market - investchronicle.com
Trump Vs. OPEC Round 2: The Great Oil Showdown of 2025 - Energy & Capital
3 E Network Technology Group Ltd’s Quiet Period Will End on February 17th (NASDAQ:MASK) - Defense World
Zhengye Biotechnology Holding Limited’s (NASDAQ:ZYBT) Quiet Period Set To Expire on February 17th - Defense World
Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising - Bamboo Works
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters’ Over-Allotment Option - GlobeNewswire
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option - The Manila Times
Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering - GlobeNewswire
ZYBT Stock Price and Chart — NASDAQ:ZYBT - TradingView
ZYBT IPO NewsChinese animal health company Zhengye Biotechnology prices US IPO at the $4 low end - Renaissance Capital
Chinese vaccine maker Zhengye Biotechnology prices IPO at $4 per share - MSN
Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering - GlobeNewswire
Zhengye Biotechnology Holding Limited (ZYBT) to Raise $7 Million in IPO - Defense World
ZYBT News Today | Why did Zhengye Biotechnology stock go down today? - MarketBeat
Chinese animal health company Zhengye Biotechnology ups share offering by 20% ahead of $7 million US IPO - renaissancecapital.com
Gold Mining Stocks ListUnearthing Opportunities in 2024 - Energy & Capital
Why Does Elon's New Lithium Refinery Reek of the CCP? - Energy & Capital
InvestorsHubNYSE, NASDAQ, AMEX, OTCBB, Pink Sheet Stock Message Boards, Stock Charts, Stock Quotes, Level II and Market News - Investors Hub
Zhengye Biotechnology Holding Ltd (ZYBT) 재무 분석
Zhengye Biotechnology Holding Ltd (ZYBT)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.38%
0.17%
자본화:
|
볼륨(24시간):